Episode 151
Paxlovid side effects, treatment timelines and more with John Farley, MD, MPH
AMA CXO Todd Unger discusses what physicians and patients need to know about Paxlovid with John Farley, MD, MPH, director of the Office of Infectious Diseases in the Center for Drug Evaluation and Research’s Office of New Drugs at the FDA. For more information on Paxlovid from the FDA, visit: https://www.fda.gov/drugs/news-events-human-drugs/fda-updates-paxlovid-health-care-providers
May 23, 202213m 45s
Audio is streamed directly from the publisher (pdst.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
AMA CXO Todd Unger discusses what physicians and patients need to know about Paxlovid with John Farley, MD, MPH, director of the Office of Infectious Diseases in the Center for Drug Evaluation and Research’s Office of New Drugs at the FDA.
For more information on Paxlovid from the FDA, visit: https://www.fda.gov/drugs/news-events-human-drugs/fda-updates-paxlovid-health-care-providers
Topics
paxlovidtimelinefdatreatmentjohn farleycovid 19which patients knewwhat physiciansmay 2022todd unger